Table 3.
Outcomes measured in included studies
| References | Dizziness-specific functioning T1/T2/T3 | Quality of life | Symptoms | Other |
|---|---|---|---|---|
| Dros [17] | DHI (median) 34/24/– Mean change 7.5 ± 19.2 |
NR | NR | NR |
| Hansson [30] | DHI 36(22)/33/35 Mean change –/−3/+2 |
NR | NR | NR |
| Maarsingh [18] | DHI 36.3 | NR | NR | NR |
| Neuhauser [2] | NR | SF-8, values NR | NR | NR |
| Sczepanek [20] | DHI: 26.68/22.95/24.32 | SF-12: 47.03/49.41/48.64 | NR | GDS: 3.19/3.08/2.63 ADL: 39.63/39.72/3953 |
| Tschan 2013 [27] | VHQ 48.70 (19.76)/39.49 (24.46)/– | *PHC (SF-36) 40.54 (10.31)/43.76 (12.19) MHC (SF-36) 40.73 (12.20)/42.57 (13.91) |
*VER (VSS-VER) 0.93 (0.50)/0.77 (0.60) Somatic AA (VSS-AA) 1.31 (0.74)/1.31 (0.89) |
GSI (SCL-90-R) 0.71 (0.46)/0.63 (0.44) |
| Yardley [28] | DHI 32.9 (18.4)/28.2 (18.7)/29.2 (18.8) | EQ-5D 0.79 (0.22)/0.79 (0.27)/0.79 (0.26) | VSS short form 13.8 (10.7)/10.5 (8.7)/11.0 (8.7) | Patients reporting improvement (n) 40 of 107 (37 %)/47/99 (47 %) |
All numbers are mean (SD) if not stated otherwise. Score values are reported for baseline/first follow-up/second follow-up if available
NR not reported, DHI dizziness handicap inventory [29], VHQ vertigo handicap questionnaire [45], SF-8,-12, -36 8-, 12-, 36-item short-form health survey [46–48], PHC physical health component, MHC mental health component, EQ-5D EuroQoL [49], VSS-VER -AA vertigo symptom scale - vertigo and related symptoms, -somatic anxiety and autonomic arousal [50], GDS geriatric depression scale [51], SCL-90-R (GSI) symptom checklist 90 (global severity index) [52], ADL activities of daily living [53]
* Difference significant